Table 1.
Risks and protective measures in DI and hyponatremia in times of COVID-19.
| Risks | Protective measures | |
|---|---|---|
| Diabetes insipidus | Dilutational hyponatraemia as side effect of desmopressin therapy | Delay desmopressin dose once or twice weekly; Advise to regularly control body weight |
| Drink to thirst | ||
| High risk for dysnatraemia if admitted to the hospital due to missed desmopressin dose, reduced fluid intake, increased insensible losses and the potential need for diuretic therapy | Endocrine consultation for every patient with DI to reduce prescribing errors and to advise with fluid management | |
| Patient empowerment | ||
| Appropriate stress dosing of corticosteroids in patients with additional ACTH deficiency | ||
| Hyponatraemia | New diagnosis of SIAD after neurosurgical interventions, brain injury or subarachnoid hemorrhage | Advise to limit fluid intake for two weeks following surgery / injury |
| Measure body weight daily and aim to stay at eunatraemic weight | ||
| Drink only to thirst | ||
| Know the early symptoms of hyponatraemia |